This Sunday, February 21, 2021, the Minister of Health of Argentina, Carla Vizzotti, approved as an “emergency” the use of the vaccine against Covid-19 developed by the Chinese pharmaceutical company Sinopharm, in the country.
The National Administration of Medicines, Food and Medical Technology (ANMAT) recommended that the Argentine authorities use these vaccines in the national vaccination process carried out by the country.
The Argentine government reached an agreement with the Chinese National Pharmaceutical Group Corporation for the acquisition of one million doses that will begin to arrive in Buenos Aires “in the next few days.”
Since the start of its vaccination plan, Argentina has received 1.22 million doses of Sputnik V and 580.000 from the Serum Institute of India, which is carried out with the technology of the British company AstraZeneca.
Be the first to comment